Objective: Preclinical models, receptor localization, and genetic linkage data support the role of D4 receptors in the etiology of ADHD. This proof-of-concept study was designed to evaluate MK-0929, a selective D4 receptor antagonist as treatment for adult ADHD. Method: A randomized, double-blind, placebo-controlled, crossover study was conducted in adults with primary ADHD. The primary end point was changed from baseline in total score on the Adult ADHD Investigator Symptom Rating Scale following a 4-week treatment regimen. Additional measures included Clinical Global Impression–Severity Scale, Hospital Anxiety and Depression Scale, and Brown Attention Deficit Disorder Scale and D4 genotype analysis. Results: No statistically significant treatment differences were found between MK-0929 and placebo in any of the primary or secondary assessments. Conclusion: Results from this study suggest that blockade of the D4 receptor alone is not efficacious in the treatment of adult ADHD.
AdlerL.CohenJ. (2004). Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatric Clinics of North America, 27, 187-201.
2.
AdlerL.SpencerT.FaraoneS.ReimherrF.KelseyD.MichelsonD.BiedermanJ. (2005). Training raters to assess adult ADHD: Reliability of ratings. Journal of Attention Disorders, 8, 121-126.
3.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
4.
AsghariV.SchootsO.van KatsS.OharaK.JovanovicV.GuanH. C.. . . Van TolH. H. (1994). Dopamine D4 receptor repeat: Analysis of different native and mutant forms of the human and rat genes. Molecular Pharmacology, 46, 364-373.
5.
AvaleM. E.FalzoneT. L.GelmanD. M.LowM. J.GrandyD. K.RubinsteinM. (2004). The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Molecular Psychiatry, 9, 718-726.
6.
BenjaminJ.LiL.PattersonC.GreenbergB. D.MurphyD. L.HamerD. H. (1996). Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nature Genetics, 12, 81-84.
7.
BiedermanJ.FaraoneS.MilbergerS.CurtisS.ChenL.MarrsA.. . . SpencerT. (1996). Predictors of persistence and remission of ADHD into adolescence: Results from a four-year prospective follow-up study. Journal of the American Academy of Child & Adolescent Psychiatry, 35, 343-351.
8.
BiedermanJ.FaraoneS. V.SpencerT.WilensT.NormanD.LapeyK. A.. . . DoyleA. (1993). Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry, 150, 1792-1798.
9.
BiedermanJ.MonuteauxM. C.MickE.SpencerT.WilensT. E.SilvaJ. M.. . . FaraoneS. V. (2006). Young adult outcome of attention deficit hyperactivity disorder: A controlled 10-year follow-up study. Psychological Medicine, 36, 167-179.
10.
CastellanosF. X.GieddJ. N.EliaJ.MarshW. L.RitchieG. F.HamburgerS. D.RapoportJ. L. (1997). Controlled stimulant treatment of ADHD and comorbid Tourette’s syndrome: Effects of stimulant and dose. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 589-596.
11.
CastellanosF. X.GieddJ. N.MarshW. L.HamburgerS. D.VaituzisA. C.DicksteinD. P.. . . RapoportJ. L. (1996). Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Archives of General Psychiatry, 53, 607-616.
12.
CastellanosF. X.LauE.TayebiN.LeeP.LongR. E.GieddJ. N.. . . SidranskyE. (1998). Lack of an association between a dopamine-4 receptor polymorphism and attention-deficit/hyperactivity disorder: Genetic and brain morphometric analyses. Molecular Psychiatry, 3, 431-434.
13.
CastellanosF. X.LeeP. P.SharpW.JeffriesN. O.GreensteinD. K.ClasenL. S.. . . RapoportJ. L. (2002). Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Medical Association, 288, 1740-1748.
14.
ChangF. M.KiddJ. R.LivakK. J.PakstisA. J.KiddK. K. (1996). The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Human Genetics, 98, 91-101.
15.
EbsteinR. P.NovickO.UmanskyR.PrielB.OsherY.BlaineD.. . . BelmakerR. H. (1996). Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nature Genetics, 12, 78-80.
16.
FaraoneS. V.BiedermanJ. (2005). What is the prevalence of adult ADHD? Results of a population screen of 966 adults. Journal of Attention Disorders, 9, 384-391.
17.
FaraoneS. V.DoyleA. E.MickE.BiedermanJ. (2001). Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. American Journal of Psychiatry, 158, 1052-1057.
FaraoneS. V.SergeantJ.GillbergC.BiedermanJ. (2003). The worldwide prevalence of ADHD: Is it an American condition?World Psychiatry, 2, 104-113.
20.
FilipekP. A.Semrud-ClikemanM.SteingardR. J.RenshawP. F.KennedyD. N.BiedermanJ. (1997). Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology, 48, 589-601.
21.
FisherS. E.FrancksC.McCrackenJ. T.McGoughJ. J.MarlowA. J.MacphieI. L.. . . SmalleyS. L. (2002). A genomewide scan for loci involved in attention-deficit/ hyperactivity disorder. American Journal of Human Genetics, 70, 1183-1196.
22.
GradyD. L.ChiH. C.DingY. C.SmithM.WangE.SchuckS.. . . MoyzisR. K. (2003). High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder. Molecular Psychiatry, 8, 536-545.
23.
HamarmanS.FossellaJ.UlgerC.BrimacombeM.DermodyJ. (2004). Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: A pharmacogenetic study. Journal of Child and Adolescent Psychopharmacology, 14, 564-574.
24.
KesslerR. C.AdlerL.BarkleyR.BiedermanJ.ConnersC. K.DemlerO.. . . ZaslavskyA. M. (2006). The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. American Journal of Psychiatry, 163, 716-723.
25.
KirleyA.LoweN.HawiZ.MullinsC.DalyG.WaldmanI.. . . GillM. (2003). Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 121, 50-54.
26.
KramerM. S.LastB.GetsonA.ReinesS. A. (1997). The effects of a selective D4 dopamine receptor antagonist (L-745, 870) in acutely psychotic inpatients with schizophrenia. Archives of General Psychiatry, 54, 567-572.
27.
KulagowskiJ. J.BroughtonH. B.CurtisN. R.MawerI. M.RidgillM. P.BakerR.. . . LeesonP. D. (1996). 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: An antagonist with high affinity and selectivity for the human dopamine D4 receptor. Journal of Medicinal Chemistry, 39, 1941-1942.
28.
KustanovichV.IshiiJ.CrawfordL.YangM.McGoughJ. J.McCrackenJ. T.. . . NelsonS. F. (2004). Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: Confirmation of association of ADHD with DRD4 and DRD5. Molecular Psychiatry, 9, 711-717.
29.
LaHosteG. J.SwansonJ. M.WigalS. B.GlabeC.WigalT.KingN.KennedyJ. L. (1996). Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Molecular Psychiatry, 1, 121-124.
30.
LichterJ. B.BarrC.KennedyJ.Van ToH.KiddK.LivakK. (1993). A hypervariable segment in the human dopamine receptor, D4 (DRD4). Human Molecular Genetics, 2, 767-773.
31.
LuthmanJ.FredrikssonA.LewanderT.JonssonG.ArcherT. (1989). Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment. Psychopharmacology (Berl), 99, 550-557.
32.
McCrackenJ. T.SmalleyS. L.McGoughJ. J.CrawfordL.Del’HommeM.CantorR. M.. . . NelsonS. F. (2000). Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Molecular Psychiatry, 5, 531-536.
33.
MillJ. S.CaspiA.McClayJ.SugdenK.PurcellS.AshersonP.. . . MoffittT. E. (2002). The dopamine D4 receptor and the hyperactivity phenotype: A developmental-epidemiological study. Molecular Psychiatry, 7, 383-391.
34.
MostofskyS. H.CooperK. L.KatesW. R.DencklaM. B.KaufmannW. E. (2002). Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder. Biological Psychiatry, 52, 785-794.
35.
OgdieM. N.MacphieI. L.MinassianS. L.YangM.FisherS. E.FrancksC.. . . SmalleyS. L. (2003). A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: Suggestive linkage on 17p11. American Journal of Human Genetics, 72, 1268-1279.
36.
PaloyelisY.MehtaM. A.KuntsiJ.AshersonP. (2007). Functional MRI in ADHD: A systematic literature review. Expert Review of Neurotherapeutics, 7, 1337-1356.
37.
PatelS.ChapmanK. L.MarstonD.HutsonP. H.RaganC. I. (2003). Pharmacological and functional characterisation of dopamine D4 receptors in the rat retina. Neuropharmacology, 44, 1038-1046.
38.
PatelS.FreedmanS.ChapmanK. L.EmmsF.FletcherA. E.KnowlesM.. . . RaganC. I. (1997). Biological profile of MK-0929, a selective antagonist with high affinity for the dopamine D4 receptor. Journal of Pharmacology and Experimental Therapeutics, 283, 636-647.
39.
PolanczykG.ZeniC.GenroJ. P.RomanT.HutzM. H.RohdeL. A. (2005). Attention-deficit/hyperactivity disorder: Advancing on pharmacogenomics. Pharmacogenomics, 6, 225-234.
40.
RomanT.SzobotC.MartinsS.BiedermanJ.RohdeL. A.HutzM. H. (2002). Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder. Pharmacogenetics, 12, 497-499.
SeamanM. I.FisherJ. B.ChangF.KiddK. K. (1999). Tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4). American Journal of Medical Genetics, 88, 705-709.
SpencerT.BiedermanJ.MadrasK.DoughertyD.BonabA.LivniE.. . . FischmanA. (2007). Further evidence of dopamine transporter receptor dysregulation in ADHD: A controlled PET imaging study using altropane. Biological Psychiatry, 62, 1059-1061.
46.
SwansonJ. M.SunoharaG. A.KennedyJ. L.ReginoR.FinebergE.WigalT.. . . WigalS. (1998). Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): A family-based approach. Molecular Psychiatry, 3, 38-41.
47.
TaraziF. I.BaldessariniR. J. (1999). Dopamine D4 receptors: Significance for molecular psychiatry at the millennium. Molecular Psychiatry, 4, 529-538.
48.
UddinL.KellyA.BiswalB.MarguliesD.ShehzadZ.ShawD.. . . MilhamM. (2008). Network homogeneity reveals decreased integrity of default-mode network in ADHD. Journal of Neuroscience Methods, 169, 249-254.
49.
Van TolH. H.WuC. M.GuanH. C.OharaK.BunzowJ. R.CivelliO.. . . JovanovicV. (1992). Multiple dopamine D4 receptor variants in the human population. Nature, 358, 149-152.
50.
VolkowN.WangG.-J.KollinsS.WigalT.NewcomJ.TelangF.. . . SwansonJ. (2009). Evaluating dopamine reward pathway in ADHD: Clinical implications. Journal of the American Medical Association, 302, 1084-1091.
51.
WilensT. E.BiedermanJ.SpencerT. J.PrinceJ. (1995). Pharmacotherapy of adult attention deficit/hyperactivity disorder: A review. Journal of Clinical Psychopharmacology, 15, 270-279.
52.
WinsbergB. G.ComingsD. E. (1999). Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. Journal of the American Academy of Child & Adolescent Psychiatry, 38, 1474-1477.
53.
ZangY.-F.YongH.Chao-ZheZ.Qing-JiuC.Man-QiuS.MengL.. . . Yu-FengW. (2009). Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI. Brain & Development, 29, 83-91.
54.
ZhangK.DavidsE.TaraziF. I.BaldessariniR. J. (2002). Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions. Psychopharmacology (Berl), 161, 100-106.
55.
ZhangK.GradyC. J.TsapakisE. M.AndersenS. L.TaraziF. I.BaldessariniR. J. (2004). Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology, 29, 1648-1655.
56.
ZhangK.TaraziF. I.BaldessariniR. J. (2001). Role of dopamine D(4) receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats. Neuropsychopharmacology, 25, 624-632.
